UK markets closed

Syndax Pharmaceuticals, Inc. (1T3.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
19.90-0.50 (-2.45%)
At close: 08:05AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
139,709
1,517
Operating expenses
Research development
185,470
163,032
118,499
88,248
50,435
Selling general and administrative
77,983
66,922
33,258
25,241
22,505
Total operating expenses
263,453
229,954
151,757
113,489
72,940
Operating income or loss
-263,453
-229,954
-151,757
26,220
-71,423
Interest expense
223
208
3,137
1,899
2,357
Total other income/expenses net
-301
-361
-316
202
-219
Income before tax
-240,634
-209,360
-149,338
24,926
-73,158
Income from continuing operations
-240,634
-209,360
-149,338
24,926
-73,158
Net income
-240,634
-209,360
-149,338
24,926
-73,158
Net income available to common shareholders
-240,634
-209,360
-149,338
24,926
-77,064
Basic EPS
-1.84
-2.98
-2.46
0.48
-1.87
Diluted EPS
-1.84
-2.98
-2.46
0.46
-1.87
Basic average shares
30,491
70,371
60,761
52,065
41,308
Diluted average shares
30,491
70,371
60,761
53,623
41,308